Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
NCT03429439 refers to a clinical study investigating the effects of Fecal Microbiota Transplantation (FMT) in patients with chronic hepatitis B (CHB). This study is a randomized trial that combines Fecal Microbiota Transplantation (FMT) with antiviral therapy. The study aims to assess the safety and efficacy of fecal microbiota transplantation (FMT) for the treatment of hepatitis B virus (HBV).
Primary outcome measures:
Change of serum hepatitis B virus e antigen(HBeAg) level
Published study results not found…